ArticleJTO clinical and research reports2023

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.

Marina C Garassino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.